Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:BLACU

Bellevue Life Sciences Acquisition (BLACU) Stock Price, News & Analysis

About Bellevue Life Sciences Acquisition Stock (NASDAQ:BLACU)

Key Stats

Today's Range
$11.74
$11.74
50-Day Range
N/A
52-Week Range
N/A
Volume
50 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BLACU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bellevue Life Sciences Acquisition and its competitors with MarketBeat's FREE daily newsletter.

BLACU Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

BLACU Stock Analysis - Frequently Asked Questions

Bellevue Life Sciences Acquisition (BLACU) raised $60 million in an initial public offering (IPO) on Friday, February 10th 2023. The company issued 6,000,000 shares at a price of $10.00 per share.

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:BLACU
CIK
N/A
Web
N/A
Phone
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

This page (NASDAQ:BLACU) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners